Nektar Therapeutics (NKTR) Stock: Buy, Sell, or Hold?
NKTR - Nektar Therapeutics
$37.72
0.83 (2.25%)
▲
5d:
-7.55%
30d:
-44.02%
90d:
-44.74%
HOLD
LOW Confidence
Analysis Updated: Oct 15, 2026 12:00 AM ET
Earnings: Nov 05, 2026
19d
Get Alerted When NKTR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NKTR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NKTR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NKTR is currently trading at $37.72, which is considered oversold relative to its 30-day fair value range of $43.69 to $68.86.
Technical Outlook: Technically, NKTR is in a strong uptrend. Immediate support is located at $36.56, while resistance sits at $47.13.
Market Sentiment: NKTR scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $133.08 (+252.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NKTR is in a strong uptrend. Immediate support is located at $36.56, while resistance sits at $47.13.
Market Sentiment: NKTR scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $133.08 (+252.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$43.69 -
$68.86
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 252.8% below Wall St target ($133.08)
- CAUTION: Bottoming setup, but lagging the sector by 45% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-7.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$43.69 -
$68.86
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$36.56
Resistance Level
$47.13
Current Trend
Strong Uptrend
Technical data as of
Oct 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.59
Wall Street Target
$133.08
(+252.8%)
Revenue Growth (YoY)
-9.3%
Profit Margin
-287.8%
Share & Embed Analysis
Last updated: October 16, 2026 7:47 AM ET
Data refreshes hourly during market hours. Next update: 8:47 AM
Data refreshes hourly during market hours. Next update: 8:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NKTR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$572 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$198 | 63 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$110 | 68 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$682 | 55 HOLD |
|
OCUL
Ocular Therapeutix Inc |
STRONG BUY
11 analysts |
$27 | 78 BUY |
